Knowledge in the field of molecular biology has a very short half-life. That is why BRAIN has always maintained an intensive exchange with academic groups.
BRAIN supports young scientists by a number of promotion programmes. On average, 10-15 doctoral theses are supported by BRAIN grants.
Presentations at BRAIN
BRAIN puts the networking concept into practice on several levels.
In-house events such as presentations for school groups and students, or lectures at universities such as TU Darmstadt and Mannheim University (since 1999) are part of the company philosophy.
Another aspect is active participation in organising technical conferences.
BRAIN is part of a widely ramified network of academic cooperation partners throughout Europe. These range from ones in the company’s direct neighbourhood, such as TU Darmstadt, to
HS Mannheim, DKFZ Heidelberg, KIT Karlsruhe, University of Stuttgart Hohenheim, RWTH Aachen, TU Darmstadt, TUBAF Bergakademie Freiberg, HZDR Dresden-Rossendorf, Juelich research centre, University of Greifswald through to INRA Dijon (France), DTU Copenhagen (Denmark), the University of Vienna and TU Graz (Austria), ETH Zurich and Basel (Switzerland), TNO and ADBC (Netherlands) and Brno University of Technology (Czech Republic) and Cambridge (United Kingdom).
BRAIN and “bright young talents”
BRAIN is part of an innovation process that links three actors: industry, small and medium-sized enterprises and academia. Here, BRAIN acts as a driver and a bridge. As an SME, it assumes the role of identifying and addressing medium-term innovative research and development themes. BRAIN focuses on up-and-coming young academics at post-doc level. The potential lies in the creative ideas of these “bright young talents” who have their finger on the pulse of the times. Through joint projects, workshops, summer school initiatives, visits and direct interaction with universities, BRAIN is actively engaged in raising enthusiasm for industrial biotechnology among young talents who are full of new ideas. In the end, both sides derive benefit, the biotechnology industry and the universities.